KNOXVILLE, TN, April 14, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced the addition of Aru Narendran, MD, PhD to the Company’s Scientific Advisory Board. Dr. Narendran is a ...
TORONTO, May 17, 2025 (GLOBE NEWSWIRE) -- Today, on DIPG Awareness Day, Brain Cancer Canada is pleased to award $68,000 for an innovative research initiative led by Dr. Aru Narendran, MD, PhD, and Dr.
Studies to explore whether exercise can help preserve pancreatic beta-cell function in patients newly diagnosed with type 1 diabetes should be conducted, say the authors of a new review. Dr Parth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results